Not Signed In - EMEA Announcement On The Cardiovascular Safety Of Non-selective Non-steroidal Anti-inflammatory Drugs (long Term Use Only - Including Ibuprofen)
Thu, 19 Oct 2006 02:00 PM EST
... On the eve of the latest announcement from the European Medicines Agency (EMEA) on the cardiovascular safety of non-selective non-steroidal anti-inflammatory drugs (NSAIDs), Reckitt Benckiser Healthcare International, manufacturers of Nurofen, calls for responsible and accurate reporting on the outcome of the review. [click link for full article] ...
Related Topics
- Long Term Care
- Cardiovascular Diseases And Disorders
- Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
- Cardiovascular Health
- Acute Care
- Food Safety
- Drug Safety
- Inflammatory Bowel Disease
- Fire Safety
- Child Safety
- Sports Safety
- Electrical Safety
- Workplace Safety & Health
- Safety (General)
- Ibuprofen
- Traffic Safety
- Safety
- Pelvic Inflammatory Disease
- Anti-inflammatory Medications
- Anti-Inflammatory Diets
email this page
print this page
bookmark this page
feedback on this page
